Beyond ACE2 downregulation: daphnetin as a multi-target agent for COVID-19 and rheumatic comorbidities. // European Journal of Pharmacology. – URL: https://www.sciencedirect.com/science/article/pii/S0014299926010125?dgcid=rss_sd_all
Beyond ACE2 downregulation: daphnetin as a multi-target agent for COVID-19 and rheumatic comorbidities. European Journal of Pharmacology. https://www.sciencedirect.com/science/article/pii/S0014299926010125?dgcid=rss_sd_all
“Beyond ACE2 downregulation: daphnetin as a multi-target agent for COVID-19 and rheumatic comorbidities.” European Journal of Pharmacology.
@article{article12450,
title = {Beyond ACE2 downregulation: daphnetin as a multi-target agent for COVID-19 and rheumatic comorbidities},
journal = {European Journal of Pharmacology},
url = {https://www.sciencedirect.com/science/article/pii/S0014299926010125?dgcid=rss_sd_all}
}